News
News and updates
Company announcements, licensing and financing milestones, publications, presentations, and development updates.
Latest
Announcement
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
Vanderbilt University Medical Center announced an agreement with Saravir Biopharma to develop a monoclonal antibody treatment for measles.
Read at VUMC NewsMedia coverage
The Race to Find a Measles Treatment as Infections Surge
The Wall Street Journal reported on efforts to develop measles therapeutics as outbreaks increase, including work by Saravir and other developers.
Read at Wall Street JournalMedia coverage
Measles Cases Hit a Record in the United States
The New York Times covered the record U.S. measles case count and the state of measles treatment development, including Saravir.
Read at The New York TimesMedia coverage
Measles Treatments Will Soon Be Needed
WIRED reported on the growing need for measles therapeutics and the companies, including Saravir, developing antibody-based approaches.
Read at WIRED